ondansetron has been researched along with sertraline in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 6 (54.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Higgins, GA; Romach, MK; Sellers, EM; Tompkins, DM | 1 |
| Grignaschi, G; Samanin, R | 1 |
| Fattinger, K; Kind, B; Krähenbühl, S; Meier-Abt, PJ | 1 |
| Grenga, A; Kenna, GA; Leggio, L; McGeary, C; McGeary, JE; Swift, RM; Wang, S; Zywiak, WH | 1 |
| Beaucage, K; Brickley, M; Clifford, JS; Fricchione, S; Haass-Koffler, CL; Kenna, GA; Leggio, L; McGeary, JE; Shoaff, JR; Swift, RM; Vuittonet, C; Zywiak, WH | 1 |
| Beaucage, K; Brickley, M; Clifford, JS; Fricchione, S; Haass-Koffler, CL; Kenna, GA; Leggio, L; McGeary, JE; Shoaff, JR; Swift, RM; Zywiak, WH | 1 |
| Arnold, S; Durbin, EB; Kolesar, J; Miller, R; Nichols, D; Weiss, HL; Wu, J | 1 |
1 review(s) available for ondansetron and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for ondansetron and sertraline
| Article | Year |
|---|---|
Serotonin and alcohol drinking.
Topics: 1-Naphthylamine; Adult; Alcohol Drinking; Alcoholism; Animals; Double-Blind Method; Fenfluramine; Humans; Male; Ondansetron; Rats; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline | 1992 |
A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
Topics: Adult; Alcoholism; DNA; Female; Genotype; Humans; Male; Middle Aged; Ondansetron; Patient Acceptance of Health Care; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Self Administration; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Socioeconomic Factors; Young Adult | 2009 |
Ondansetron reduces naturalistic drinking in nontreatment-seeking alcohol-dependent individuals with the LL 5'-HTTLPR genotype: a laboratory study.
Topics: Adult; Aged; Alcohol Drinking; Alcoholism; Female; Genotype; Humans; Male; Middle Aged; Ondansetron; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Young Adult | 2014 |
Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: exploratory findings.
Topics: Adult; Alcoholism; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Ondansetron; Polymorphism, Genetic; Receptors, Dopamine D4; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2014 |
6 other study(ies) available for ondansetron and sertraline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Role of serotonin receptors in the effect of sertraline on feeding behaviour.
Topics: 1-Naphthylamine; Animals; Brain Chemistry; Dopamine; Eating; Feeding Behavior; Food Deprivation; Male; Metergoline; Norepinephrine; Ondansetron; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline; Sympathectomy, Chemical | 1993 |
[The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Topics: 1-Naphthylamine; Antidepressive Agents; Antiemetics; Depression; Drug Interactions; Female; Humans; Ondansetron; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 1996 |
Pharmacogenomic potential in advanced cancer patients.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Capecitabine; Drug Prescriptions; Female; Humans; Male; Middle Aged; Neoplasms; Ondansetron; Pharmacogenomic Testing; Pharmacogenomic Variants; Precision Medicine; Prospective Studies; Retrospective Studies; Sertraline | 2019 |